Anastasis: Cell Survival Mechanism

Authors

  • Abolaji S. Olagunju Department of Biochemistry, University of Ibadan, Nigeria
  • Folashade G. Olorunfemi Department of Biochemistry, College of Medicine, University of Lagos, Nigeria
  • John O. Teibo Department of Biochemistry, University of Ibadan, Nigeria
  • Abiodun M. Adewolu Department of Biochemistry, College of Medicine, University of Lagos, Nigeria

DOI:

https://doi.org/10.17140/CSMMOJ-6-131

Keywords:

Anastasis, Programmed cell death, Cancer, Pro-metastatic factor, Pro-survival factor, Genetic instability, Cell cycle arrest

Abstract

Equilibrium between cell survival and death is important for normal cell homeostasis and development and also for inhibiting
pathologies particularly cancer. Anastasis is a natural cell recovery phenomenon that rescues cells from the brink of death or a
mechanism by which cells recuperate from apoptotic lesions and return to its normal active and functioning state. Programmed
cell death (apoptosis) was known to be an intrinsically irreversible cascade that commits cells to a rapid destruction. However,
recent studies have demonstrated the possibility of recovering dying cells even at the late stages. Anastasis uses the usual pro-metastatic
and pro-survival factors to inhibit apoptotic progression. Epithelial mesenchymal transition (EMT) activation and its related
modulators is not only linked with cellular metastasis and survivability but also widely associated with the stemness of cancer cells.

References

Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000; 408: 433-439. doi: 10.1038/35044005

Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21: 485-495. doi: 10.1093/carcin/21.3.485

Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. Mu-tationalinactivation of theproapoptotic gene BAX confers selec-tive advantage during tumor clonal evolution. Proc Natl Acad Sci. 2000, 97: 10872-10877. doi: 10.1073/pnas.190210897

Sun G, Guzman E, Balasanyan V, Conner CM, Wong K, Zhou HR, et al. A molecular signature for anastasis, recovery from the brink of apoptotic cell death. J Cell Biol. 2017; 216(10): 3355- 3368. doi: 10.1083/jcb.20170 6134

Lovric MM, Hawkins CJ. TRAIL treatment provokes mutations in surviving cells. Oncogene. 2010; 29: 5048-5060. doi: 10.1038/ onc.2010.242

Bell RAV, Megeney LA. Evolution of caspase-mediated cell death and differentiation: Twins separated at birth. Cell Death Dif-fer. 2017; 24: 1359-1368. doi: 10.1038/cdd.2017.37

Hanahan D, Weinberg RA. Hallmarks of cancer: The next gen-eration. Cell. 2011; 144: 646-674. doi: 10.1016/j.cell.2011.02.013

Baritaki S, Militello L, Malaponte G, Spandidos DA, Salcedo M, Bonavida B. The anti-CD20 mAb LFB-R603 interrupts the dys-regulated NF-kB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis. Int J Oncol. 2011; 38: 1683-1694. doi: 10.3892/ijo.2011.984

Tan ML, Ooi JP, Ismail N, Moad AIH, Muhammad TST. Pro-grammed cell death pathways and current antitumor targets. Pharm Res. 2009; 26: 1547-1560. doi: 10.1007/s11095-009-9895-1

Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: Recommen-dations of the Nomenclature Committee on cell death 2009. Cell Death Differ. 2009; 16: 3-11. doi: 10.1038/cdd.2008.150

Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Commit-tee on Cell Death 2012. Cell Death Differ. 2012; 19: 107-120. doi: 10.1038/ cdd.2011.96

Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018; 25: 486-541. doi: 10.1038/ s41418-017-0012-4

Fuchs Y, Steller H. Programmed cell death in animal devel-opment and disease. Cell. 2011; 147: 742-758. doi: 10.1016/j. cell.2011.10.033 10 Olagunju AS et al

Reddien PW, Cameron S, Horvitz HR. Phagocytosis promotes programmed cell death in C. elegans. Nature. 2001; 412: 198-202. doi: 10.1038/35084096

Hoeppner DJ, Hengartner MO, Schnabel R. Engulfment genes cooperate with ced-3 to promote cell death in Caenorhab-ditiselegans. Nature. 2011; 412: 202-206. doi: 10.1038/35084103

Holland AJ, Cleveland DW. Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chro-mosomal rearrangements. Nat Med. 2012; 18: 1630-1638. doi: 10.1038/nm.2988

Burke PJ. Mitochondria, bioenergetics and apoptosis in cancer. Trends Cancer 20.17; 3: 857-870. doi: 10.1016/j.trecan.2017.10.006

Alberts B, Johnson A, Lewis J, Morgan D, Raff M, Roberts K, Walter P. Cell death. In: Molecular Biology of the Cell. 6th ed. New York, NY, USA: Garland Science, Taylor and Francis Group; 2014: 1021-1034.

Julien O, Wells JA. Caspases and their substrates. Cell Death Differ. 2017; 24: 1380-1389. doi: 10.1038/cdd.2017.44

Marin ˜o G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: The interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014; 15: 81-94. doi: 10.1038/nrm3735

Tang HL, Tang HM, Mak KH, Hu S, Wang SS, Wong KM, et al. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol Biol Cell. 2012; 23: 2240-2252. doi: 10.1091/mbc.E11-11-0926

Liu X, He Y, Li F, Huang Q, Kato TA, Hall RP, Li CY. Cas-pase-3 promotes genetic instability and carcinogenesis. Mol Cell. 2015; 58: 284-296. doi: 10.1016/j.molcel.2015.03.003

Sun G, Montell DJ. Q&A: Cellular near death experiences— what is anastasis? BMC Biol. 2017; 15(1): 92. doi: 10.1186/s12915- 017-0441-z

Cartwright IM, Liu X, Zhou M, Li F, Li C-Y. Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis. Elife. 2017; 6: e26371. doi: 10.7554/eLife.26371

P´erez E, Lindblad JL, Bergmann A. Tumor-promoting function of apoptotic caspases by an amplification loop involv-ing ROS, macrophages and JNK in Drosophila. Elife. 2017; 6: e26747. doi: 10.7554/eLife.26747

KenisH, Zandbergen HR, Hofstra L, Petrov AD, Dumont EA, et al. Annexin A5 uptake in ischemic myocardium: Demon-stration of reversible phosphatidylserine externalization and fea-sibility of radionuclide imaging. J Nucl Med. 2010; 51(2): 259-267. doi: 10.2967/jnumed.109.068429

de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, et al. Caspase activation precedes and leads to tangles. Nature. 2010; Review | Volume 6 | Number 1| 464(7292): 1201-1204. doi: 10.1038/nature08890

Iwakuma T, Lozano G. MDM2, an introduction. Mol Cancer Res. 2003; 1(14): 993-1000.

Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, et al. Limited mitochondrial permeabilization causes DNA dam-age and genomic instability in the absence of cell death. Mol Cell. 2015; 57(5): 860-872. doi: 10.1016/j.molcel.2015.01.018

Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Mat-suda F, Nagata S. Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science. 2014; 344: 1164-1168. doi: 10.1126/science.1252809

Arandjelovic S, Ravichandran KS. Phagocytosis of apop-totic cells in homeostasis. Nat Immunol. 2015; 16: 907-917. doi: 10.1038/ni. 3253

Salameh A, Galvagni F, Anselmi F, De Clemente C, Orlandini M, Oliviero S. Growth factor stimulation induces cell survival by c-Jun• ATF2-dependent activation of Bcl- XL. J Biol Chem. 2010; 285(30): 23096-23104. doi: 10.1074/jbc.M109.087221

Elliott MR, Ravichandran KS. The dynamics of apoptotic cell clearance. Dev Cell. 2016; 38: 147-160. doi: 10.1016/j.dev-cel.2016.06.029

Tang HM, Fung MC, Tang HL. Detecting anastasis in vivo by Caspase Trackerbiosensor. J Vis Exp. 2018; 132: e54107. doi: 10.3791/54107

Tang HL, Tang HM, Hardwick JM, Fung MC. Strategies for tracking anastasis, a cell survival phenomenon that reverses apop-tosis. J Vis Exp. 2015; 96: e51964. doi: 10.3791/51964

Gu L, Zhu N, Zhang H, Durden DL, Feng Y, Zhou M. Regu-lation of XIAP translation and induction by MDM2 following Submit your article to this journal | https://openventio.org/submit-manuscript/ Review | Volume 6 | Number 1| Olagunju AS et al irradiation. Cancer Cell. 2009; 15: 363-375. doi: 10.1016/j.ccr. 2009.03.002

Tang H, Yuen K, Tang H, Fung M. Reversibility of apoptosis in cancer cells. Br J Cancer. 2009; 100(1): 118-122. doi: 10.1038/ sj.bjc.6604802

Flanagan L, Sebastia J, Tuffy LP, Spring A, Lichawska A, De-vocelle M, et al. XIAP impairs Smac release from the mitochon-dria during apoptosis. Cell Death Dis. 2010; 1: e49. doi: 10.1038/ cddis.2010.26

Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016; 17: 611-625. doi: 10.1038/nrm.2016.87

Hustedt N, Durocher D. The control of DNA repair by the cell cycle. Nat Cell Biol. 2016; 19: 1-9. doi: 10.1038/ncb3452

Tang HM, Talbot Jr CC, Fung MC, Tang HL. Molecular signa-ture of anastasis for reversal of apoptosis. F1000Res. 2017; 6: 43. doi: 10.12688/f1000research.10568.2

Abay ZC, Wong MY, Teoh JS, Vijayaraghavan T, Hilliard MA, Neumann B. Phosphatidylserine save-me signals drive func-tional recovery of severed axons in Caenorhabditiselegans. Proc Natl Acad Sci. 2017; 114: E10 196-E10 205. doi: 10.1073/pnas. 1703807114

Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, et al. A nonapoptotic cell death process, en-tosis, that occurs by cell-in-cell invasion. Cell. 2007; 131: 966-979. doi: 10.1016/j.cell. 2007.10.040

Taylor RC, Cullen SP, Martin SJ. Apoptosis: Controlled demo-lition at the cellular level. Nat Rev Mol Cell Biol. 2008; 9: 231-241. doi: 10.1038/ nrm2312

Downloads

Published

2020-09-03

How to Cite

Abolaji S. Olagunju, Folashade G. Olorunfemi, John O. Teibo, & Abiodun M. Adewolu. (2020). Anastasis: Cell Survival Mechanism. Cancer Studies and Molecular Medicine , 6(1), 5–11. https://doi.org/10.17140/CSMMOJ-6-131

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.